Readers seeking what is verifiable, what is brand-stated, and what is unverified should continue reading
Whats New: ASCO GI 2026 Data on GLP-1 Agents At ASCO GI 2026, several large-scale analyses presented the strongest clinical signals to date linking GLP-1 receptor agonist use with reduced colorectal neoplasia risk
They are used, when appropriate, within a broader GLP-1 Weight Loss for Longevity framework that emphasizes body composition, metabolic health, protein adequacy, resistance training, cardiovascular risk reduction, and long-term maintenance
If you or someone you love is struggling with alcohol use and also meets criteria for a GLP-1 prescription (typically type 2 diabetes or a BMI over 30), its worth having a conversation with a healthcare provider about whether these medications might serve a dual purpose
No, tirzepatide should never be frozen
Patient Perspective: Several of my South Asian patients have found success with Saxenda because the daily dosing gives them a sense of control and consistency with their weight management routine
.png)
